ERBB2 and cancer: Notably, in HER2+ cells we assessed the existence of an Akt/GSK3β/β-catenin axis that can be up-modulated by DADS and that culminates in the accumulation of β-catenin inside the cell nucleus, where it is known to affect expression of genes involved in various cancer related events [68,69].